Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Aarcoron Apr 08, 2021 5:32pm
211 Views
Post# 32963673

RE:RE:Some calls about some things...

RE:RE:Some calls about some things...
chrispi wrote:
The thing that caused me the most grief from shareholders yesterday and today is that the corporate presentation (CP) still has the Q1 CY2021 data delivery predictions on it. Sorry folks. I cannot explain that one. Not even going to try. The company needs to edit page 4 of that document. Make another prediction or remove the prediction. 
 
I can explain it JD and thought I did with my post from a few days ago, that is:
 
This news has nothing to do with the study data readouts that are to be completed by the end of Q1/2021 and subsequently press released in the following weeks. I personally do not want to see three study readouts in one press release nor three separate press releases all announced on the same day as that is simply too much news for all interested parties to digest at once and makes no sense to do it that way. Let’s release them individually and allow them to be distributed and understood by the market. I’m certain shareholders and (potential) partners will be impressed! From my understanding, the studies we are awaiting data readouts for are in the 007, 004 and Progranulin programs.



Hi Chrispi, I hope you're feeling well today and the nice lady let you have some time at the internet computer today.

Back in December, I pointed out that Rathjen indicated high likelihood of more than one additional partnerships/deals before end of 2020.  That did not happen and you were quick to jump to the defence to ask would we all still be upset when the deals were announced a week or two into January.  Obviously that did not happen either.  Now you are saying that the data that was promised in Q1 really meant the study would be concluded in Q1 and now the data will arrive sometime soon.  So I have some questions:

1) Will there be any situation where you will be disappointed that management has missed another self-imposed deadline for a deliverable ?  Will management ever be accountable ?
2) Does your daily timetable have the nice lady provide your medication just prior to internet computer time ?

If the answer to 2) is yes, then it explains why the answer to 1 is always "no".  If the answer to 2) is no, are you Rathjen ?
<< Previous
Bullboard Posts
Next >>